Evidence map›Paper›PMID 11722648›Full record

ArticleImmunology2001

Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4.

T Yoshikawa, T Imada, H Nakakubo, N Nakamura, K Naito

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

T YoshikawaPharmaceutical Research Division, Mitsubishi Pharma Corporation, Osaka, Japan.
T Imada
H Nakakubo
N Nakamura
K Naito

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cell chymase plays important roles in inflammation and tissue remodeling. Here we show that mast cell chymase also functions as an enhancer of immunoglobulin production. In the culture of murine spleen cells stimulated with lipopolysaccharide and interleukin-4, purified rat chymase (rat mast cell protease-I; RMCP-I), at physiological concentrations, enhanced immunoglobulin E (IgE) and IgG1 syntheses but not IgG3 synthesis. The enhancement was also evident when spleen cells depleted of T cells and macrophages were employed as responding cells. Enzymatic activity of RMCP-I was required to enhance IgE and IgG1, because two inhibitors for chymotryptic enzymes, chymostatin and Y-40613, a novel chymase inhibitor, suppressed the enhanced immunoglobulin production, and phenylmethylsulphonyl fluoride, an irreversible inhibitor for serine proteases, totally abolished the enhancing effect. Furthermore, a specific inhibitor for Zn2+-dependent metalloproteases, GI 129471, could also completely inhibit the production of IgE and IgG1 that was enhanced by RMCP-I, suggesting that a metalloprotease also played an essential role in the immunoglobulin production. Our results together with others show that proteases from mast cell granules have important function not only in the efferent phase but also in the afferent phase of immune responses.

Indexed as

AnimalsB-LymphocytesCattleCell Culture TechniquesChymasesDose-Response Relationship, ImmunologicFemaleImmunoglobulin EImmunoglobulin GInterleukin-4Lymphocyte ActivationMast CellsMatrix Metalloproteinase 1Matrix Metalloproteinase InhibitorsMatrix MetalloproteinasesMiceChymasesGI 129471Immunoglobulin EImmunoglobulin GInterleukin-4Matrix Metalloproteinase 1Matrix Metalloproteinase InhibitorsMatrix MetalloproteinasesPhenylalanineSerine EndopeptidasesSerine Proteinase Inhibitors

Identifiers

PMID11722648
PMCPMC1783305
OpenAlexW1978887461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.